Transport of amino acid esters and the amino-acid-based prodrug valganciclovir by the amino acid transporter ATB0,+

被引:52
作者
Umapathy, NS
Ganapathy, V
Ganapathy, ME [1 ]
机构
[1] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA
[2] Med Coll Georgia, Dept Biochem, Augusta, GA 30912 USA
[3] Med Coll Georgia, Dept Mol Biol, Augusta, GA 30912 USA
关键词
amino acid esters; amino acid transporter ATB(0; drug delivery; valganciclovir;
D O I
10.1023/B:PHAM.0000033019.49737.28
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of this study was to analyze the transport of amino acid esters and the amino-acid-based prodrug valganciclovir by the Na+/Cl-- coupled amino acid transporter ATB(0,+). Methods. The interaction of amino acid esters and valganciclovir with the cloned rat ATB(0,+) was evaluated in a mammalian cell expression system and in the Xenopus oocyte expression system. Results. In mammalian cells, expression of ATB(0,+) induced glycine uptake. This uptake was inhibited by valine and its methyl, butyl, and benzyl esters. The benzyl esters of other neutral amino acids were also effective inhibitors. Valganciclovir, the valyl ester of ganciclovir, was also found to inhibit ATB(0,+)- mediated glycine uptake competitively. Exposure of ATB(0,+)- expressing oocytes to glycine induced inward currents. Exposure to different valyl esters ( methyl, butyl, and benzyl), benzyl esters of various neutral amino acids, and valganciclovir also induced inward currents in these oocytes. The current induced by valganciclovir was saturable with a K-0.5 value of 3.1 +/- 0.7 mM and was obligatorily dependent on Na+ and Cl-. The Na+: Cl-: valganciclovir stoichiometry was 2 or 3: 1: 1. Conclusions. Amino acid esters and the amino-acid-based prodrug valganciclovir are transported by ATB(0,+). This shows that ATB(0,+) can serve as an effective delivery system for amino acid - based prodrugs.
引用
收藏
页码:1303 / 1310
页数:8
相关论文
共 18 条
[1]   Mechanism of corneal permeation of L-valyl ester of acyclovir: Targeting the oligopeptide transporter on the rabbit cornea [J].
Anand, BS ;
Mitra, AK .
PHARMACEUTICAL RESEARCH, 2002, 19 (08) :1194-1202
[2]   Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers [J].
Brown, F ;
Banken, L ;
Saywell, K ;
Arum, I .
CLINICAL PHARMACOKINETICS, 1999, 37 (02) :167-176
[3]  
DEMIRANDA P, 1994, DRUG METAB DISPOS, V22, P55
[4]   Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells [J].
Friedrichsen, GM ;
Chen, WQ ;
Begtrup, M ;
Lee, CP ;
Smith, PL ;
Borchardt, RT .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 16 (1-2) :1-13
[5]   Valacycloviv: A substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2 [J].
Ganapathy, ME ;
Huang, W ;
Wang, H ;
Ganapathy, V ;
Leibach, FH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 246 (02) :470-475
[6]  
GANAPATHY V, 2004, AMINO ACID METABOLIS, P63
[7]   5′-amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter [J].
Han, HK ;
de Vrueh, RLA ;
Rhie, JK ;
Covitz, KMY ;
Smith, PL ;
Lee, CP ;
Oh, DM ;
Sadee, W ;
Amidon, GL .
PHARMACEUTICAL RESEARCH, 1998, 15 (08) :1154-1159
[8]   Transport of amino acid-based prodrugs by the Na+- and Cl- -coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery [J].
Hatanaka, T ;
Haramura, M ;
Fei, YJ ;
Miyauchi, S ;
Bridges, CC ;
Ganapathy, PS ;
Smith, SB ;
Ganapathy, V ;
Ganapathy, ME .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (03) :1138-1147
[9]   Transport of D-serine via the amino acid transporter ATB0,+ expressed in the colon [J].
Hatanaka, T ;
Huang, W ;
Nakanishi, T ;
Bridges, CC ;
Smith, SB ;
Prasad, PD ;
Ganapathy, ME ;
Ganapathy, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 291 (02) :291-295
[10]   Na+- and Cl--coupled active transport of nitric oxide synthase inhibitors via amino acid transport system B0,+ [J].
Hatanaka, T ;
Nakanishi, T ;
Huang, W ;
Leibach, FH ;
Prasad, PD ;
Ganapathy, V ;
Ganapathy, ME .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (08) :1035-1043